Aveo logo
Startup

Aveo

See Aveo's full profile

BOOK A DEMO
Headquarters

Germany

Founded Year

2021

Total Funding

Employees Status

Active


About Aveo

Aveo gives manufacturers the tools to uplevel their current workforce from within to become drivers of innovation and to live up to their full potential.

Headquarters

Weinbergsweg 24, 10119 Berlin, Germany


General Information on Aveo

Brand name Aveo
Company name Dekant Ventures UG (haftungsbeschränkt)
Register number HRB 226644
Website https://aveo.one/
Founded year 2021
Employees None
Contact [email protected]
+4915141910407

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Aveo

Investors Observer 30.06.2022
Is AVEO Pharmaceuticals, Inc. (AVEO) a Good Buy in the Healthcare Sector?

AVEO Pharmaceuticals, Inc. ( AVEO ) is near the top in its sector according to InvestorsObserver . AVEO gets an overall rating of 92. That means it scores higher than 92% of stocks. AVEO Pharmaceuticals, Inc. gets a 99 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors. AVEO has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on AVEO! What do These Ratings Mean? Trying to find the ...

Aveo news
Tender Detail 28.06.2022
Supply Of Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 350 Strips ] Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 350 Strips ] , Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 3

TDR No Tendering Authority Click Here To View Tendering Authority. Tender Brief Supply Of Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 350 Strips ] Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 350 Strips ] , Blood Glucose Testing Strips My Life Aveo Or Similar With One Meter Per 3 Compitition Type Indian State Uttar Pradesh Publish Date Due Date Tender Documents Click Here To ...

India Mart 28.06.2022
Supply of Blood Glucose Testing Strips my Life Aveo or Similar with One Meter Per 350 Strips, 90.00 Numbers at LUCKNOW., Uttar Pradesh

Sugar Test Strips Tender Posted on : 28 Jun, 2022 Tender Details: Blood Glucose Testing Strips My Life aveo Or Similar With One meter Per 350 Strips] Tender Doc. Cost (INR) : 0.00 Earnest Money (INR) : 0.00 Tender Closing Date Time : 08/07/2022 11:30 Tender Type : Limited - Indigenous Contract Category : Expenditure Evaluation Criteria : Itemwise/Consigneewise Bidding System : Single Packet Pre-Bid Conference Required : No Pre-Bid ...

Baseball News Source 28.06.2022
AVEO Pharmaceuticals (NASDAQ:AVEO) Stock Crosses Above Two Hundred Day Moving Average of $4.51

AVEO Pharmaceuticals, Inc. ( NASDAQ:AVEO – Get Rating ) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $4.51 and traded as high as $6.89. AVEO Pharmaceuticals shares last traded at $6.67, with a volume of 426,003 shares traded. Several research analysts have commented on AVEO shares. Jonestrading started coverage on shares of AVEO Pharmaceuticals in a report on ...

Aveo news
Lexology 27.06.2022
Alvotech dual NASDAQ listing, Samsung Bioepis/Samil ranibizumab, Formycon Q1/22 results, Daiichi Sankyo trastuzumab deruxtecan, Midas Pharma's ranibizumab, Celltrion's bevacizumab, Merck's pembrolizumab, AVEO/Eli Lilly agreement, Innovent's sintilimab

Australia June 27 2022 20 Jun 22 | CN | NMPA approves Innovent's TYVYT® (sintilimab injection) Innovent Biologics and Eli Lilly announced that the CDE of China's NMPA has approved the sNDA for TYVYT® ( sintilimab injection) in combination with cisplatin plus paclitaxel or cisplatin plus 5-FU chemotherapy for the first-line treatment of unresectable, locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC). 21 Jun ...

Aveo news
Marketscreener DE 23.06.2022
Aveo Pharmaceuticals, Inc. kündigt Kooperations- und Liefervereinbarung mit Eli Lilly and Company für Erbitux® (Cetuximab) in Nordamerika an, um Ficlatuzumab und Cetuximab bei Patienten mit rezidivierendem oder metastasiertem Hnscc zu untersuchen

22.06.2022 | 14:00 AVEO Pharmaceuticals, Inc. gab bekannt, dass das Unternehmen in Nordamerika mit Eli Lilly and Company (Lilly) eine Vereinbarung über die Zusammenarbeit bei klinischen Studien und die Lieferung von Ficlatuzumab in Kombination mit ERBITUX® (Cetuximab), einem Anti-EGFR-Antikörper, bei Patienten mit rezidivierendem oder metastasiertem Plattenepithelkarzinom des Kopfes und Halses (R/M HNSCC) geschlossen hat. Ficlatuzumab ist AVEOs ...

Aveo news
MarketWatch 22.06.2022
AVEO Oncology Shares Rise 10% After Lilly Collaboration, Supply Agreement

By Chris Wack AVEO Oncology Inc. shares were up 10% at $5.27 after the company said it was in a clinical trial collaboration and supply agreement in North America with Eli Lilly & Co. to evaluate ficlatuzumab in combination with Erbitux cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma. The stock closed Tuesday's session 7% higher. Under the terms of the agreement, Lilly will provide cetuximab clinical ...

Aveo news
Yahoo! Finance 22.06.2022
Strong week for AVEO Pharmaceuticals (NASDAQ:AVEO) shareholders doesn't alleviate pain of five-year loss

Simply Wall St · 3 min read In this article: AVEO This week we saw the AVEO Pharmaceuticals, Inc. NASDAQ:AVEO ) share price climb by 20%. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. Five years have seen the share price descend precipitously, down a full 77%. It's true that the recent bounce could signal the company is turning over a new leaf, but we are not so sure. The real question is whether the ...

Aveo news
Investors Hangout 22.06.2022
$AVEO News Article - AVEO Oncology Announces Clini

$AVEO News Article - AVEO Oncology Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ERBITUX (cetuximab) in North America to Evaluate Ficlatuzumab and Cetuximab in Patients with Recurrent or Metastatic HNSCC https://marketwirenews.com/news-releases/aveo...81424.html Aveo Pharmaceuticals (AVEO) Stock Research Links My Twitter: WhyteStocks

Aveo news
Swissquote 22.06.2022
BUZZ-Aveo Pharma rises on collaboration with Eli Lilly for cancer drug trial

** Aveo Pharmaceuticals' shares rise 3% to $4.95 premarket ** Co enters into clinical trial collaboration and supply pact in North America with Eli Lilly and Co to evaluate AVEO's ficlatuzumab in combination with LLY's Erbitux in patients with recurrent or metastatic head and neck skin cancer ** In discussions with regulators on design of a potential pivotal study for this combination therapy, which is expected to start in H1 2023 - AVEO ** ...